Hexagon Capital Partners LLC Novartis Ag Transaction History

Hexagon Capital Partners LLC

$508 Million
Q3 2024

A detailed history of Hexagon Capital Partners LLC transactions in Novartis Ag stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 3,495 shares of NVS stock, worth $339,294. This represents 0.08% of its overall portfolio holdings.

Number of Shares

3,495

Previous 3,560 1.83%

Holding current value

$339,294

Previous $378,000 6.08%

% of portfolio

0.08%

Previous 0.08%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$106.13 - $120.89 $6,898 - $7,857	-65 Reduced 1.83%	3,495 $401,000
Q2 2024 Jul 12, 2024	SELL	$92.57 - $107.37 $4,906 - $5,690	-53 Reduced 1.47%	3,560 $378,000
Q1 2024 Apr 18, 2024	SELL	$95.27 - $108.47 $22,960 - $26,141	-241 Reduced 6.25%	3,613 $349,000
Q4 2023 Feb 05, 2024	BUY	$92.27 - $101.54 $108,048 - $118,903	1,171 Added 43.65%	3,854 $389,000
Q3 2023 Oct 23, 2023	BUY	$94.73 - $105.13 $14,588 - $16,190	154 Added 6.09%	2,683 $273,000
Q2 2023 Jul 24, 2023	BUY	$92.52 - $104.91 $36,915 - $41,859	399 Added 18.73%	2,529 $255,000
Q1 2023 Apr 24, 2023	BUY	$80.03 - $92.81 $12,804 - $14,849	160 Added 8.12%	2,130 $195,000
Q4 2022 Jan 13, 2023	SELL	$75.55 - $92.52 $1,359 - $1,665	-18 Reduced 0.91%	1,970 $0
Q3 2022 Oct 17, 2022	BUY	$74.61 - $87.26 $36,185 - $42,321	485 Added 32.27%	1,988 $151,000
Q2 2022 Jul 21, 2022	BUY	$80.52 - $93.75 $40,340 - $46,968	501 Added 50.0%	1,503 $127,000
Q1 2022 Apr 13, 2022	BUY	$80.11 - $90.62 $7,770 - $8,790	97 Added 10.72%	1,002 $88,000
Q1 2021 May 13, 2021	SELL	$83.5 - $98.47 $14,445 - $17,035	-173 Reduced 16.05%	905 $77,000
Q3 2020 Nov 10, 2020	BUY	$82.14 - $91.0 $88,546 - $98,098	1,078 New	1,078 $85,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.

Account

Hexagon Capital Partners LLC Novartis Ag Transaction History